Clinical trials: Well Differentiated Liposarcoma
Liposarcoma, Atypical Lipomatous Tumor
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas
The main objective of this project is to identify a new non-invasive biological test for the diagnosis of LPS by measuring circulating serine levels. The current gold standard is the detection of Mdm2 amplification by the FISH.
- Trial name
- ESPACE (NCT04224064)
- Testing
- Blood sampling
- Where
- France
- Volunteers
- 158 people, healthy volunteers welcome
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle